Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-34 - Early Assessment of Therapy Response in Non-Small Cell Lung Cancer (NSCLC) via Longitudinal ctDNA Analysis
09:45 - 09:45 | Presenter: Stephanie Yaung | Author(s): Xiaoju Max Ma, Christine Ju, Corinna Woestmann, Liu Xi, Bernd Hinzmann, Michael Thomas, Claus-Peter Heussel, Felix Lasitschka, Michael Meister, Marc Andre Schneider, Felix Herth, Thomas Muley, Birgit Wehnl, John F. Palma
- Abstract
Loading... -
+
P1.01-58 - Comprehensive Serial Biomaterial Acquisition in Advanced NSCLC: Feasibility, Challenges and Perspectives
09:45 - 09:45 | Presenter: Marc Andre Schneider | Author(s): Sabine Wessels, Petros Christopoulos, Thomas Muley, Michael Meister, Ingrid Heinzmann-Groth, Arne Warth, Esther Herpel, Albrecht Stenzinger, Simone Hummler, Ursula Klingmueller, Jonas Kuon, Claus-Peter Heussel, Ralf Eberhardt, Felix Herth, Hauke Winter, Helge Bischoff, Martin Reck, Rudolf Maria Huber, Michael Thomas
- Abstract
Loading...
-
+
MA13 - Going Back to the Roots!
- 14:00 - 15:30
- 9/09/2019
- Location: Vancouver (2003)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Maurice Perol, Kaoru Kubota
-
+
MA13.05 - Nab-Paclitaxel Maintenance in Squamous Non-Small Cell Lung Cancer (NSCLC): Updated Results of the Phase III ABOUND.sqm Study
14:30 - 14:35 | Presenter: David R Spigel | Author(s): Robert M Jotte, Santiago Ponce Aix, Laurent Gressot, Daniel Morgensztern, Michael McCleod, Mark A Socinski, Davey Daniel, Oscar Juan, Kathryn F Mileham, HOWARD WEST, Ray Page, Niels Reinmuth, Jeanna Knoble, Olivia Yu Tian, Rafia Bhore, Marianne Wolfsteiner, Teng Jin Ong, Cesare Gridelli, Michael Thomas
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-02 - CANOPY-A: A Phase 3 Study of Canakinumab as Adjuvant Therapy in Patients with Surgically Resected NSCLC
10:15 - 10:15 | Presenter: Edward Garon | Author(s): Andrea Ardizzoni, Fabrice Barlesi, Byoung Chul Cho, Pedro De Marchi, Yasushi Goto, Shun Lu, Luis Paz-Ares, David R Spigel, Michael Thomas, Bijoyesh Mookerjee, Pilar Cazorla Arratia, Jason Baum, Zhu Zewen, James Chih-Hsin Yang
- Abstract
Loading... -
+
P2.01-07 - Open-Label, Biomarker-Directed Platform Study in NSCLC Patients Who Progressed on an Anti-PD-(L)1-Containing Therapy (HUDSON)
10:15 - 10:15 | Presenter: Si-Houy Lao-Sirieix | Author(s): John Victor Heymach, Patrick M. Forde, Michael Thomas, Keunchil Park, Benjamin Besse, Mark Awad, Glenwood D. Goss, Naiyer A Rizvi, Helen A Ambrose, Wouter Hanekom, Steven Fox, Philip J Jewsbury, Gayle P Pouliot, Peter G Mortimer, Sabina I Patel, Kris Sachsenmeier, J.C Barrett, M Stuart, Z Szucs, L Walton
- Abstract
Loading...
-
+
P2.03 - Biology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Biology
-
+
P2.03-04 - The Prognostic Value of Serological Tumor Markers in Lung Cancer – Analysis of 13,373 Cases
10:15 - 10:15 | Presenter: Thomas Muley | Author(s): Karsten Senghas, Sonja Kobinger, Michael Meister, Marc Andre Schneider, Esther Herpel, Michael Thomas, Hauke Winter, Claus-Peter Heussel, Felix Herth
- Abstract
Loading... -
+
P2.03-25 - Assessing the Impact of Clonal Hematopoiesis in Disease Monitoring Using Targeted Cell-Free DNA (cfDNA) Sequencing Technology
10:15 - 10:15 | Presenter: Stephanie Yaung | Author(s): Liu Xi, Corinna Woestmann, Christine Ju, Daniel M. Klass, Fergal Casey, Bernd Hinzmann, Claus-Peter Heussel, Michael Thomas, Felix Herth, Thomas Muley, Birgit Wehnl, John F. Palma, Xiaoju Max Ma
- Abstract
Loading...
-
+
MA21 - Non EGFR/MET Targeted Therapies
- 14:30 - 16:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Benjamin Besse, Michael Thomas
-
+
MA21.01 - Generation and Characterization of Novel Preclinical Disease Models of NSCLC with NRG1 Rearrangements to Improve Therapy
14:30 - 14:35 | Presenter: Eric Gladstone | Author(s): Morana Vojnic, Michael Offin, Lukas Delasos, Allan J. W. Lui, Evan Siau, Hirko Sato, Ryma Benayed, Renate Kurth, Marissa Mattar, Inna Khodos, Elisa De Stanchina, Robert Daly, Alison Schram, Alexander Drilon, Marc Ladanyi, Romel Somwar
- Abstract
Loading... -
+
MA21.02 - Genomic Origin and EGFR-TKI Efficacy of Pulmonary Adenosquamous Carcinoma
14:35 - 14:40 | Presenter: Gen Lin | Author(s): Chao Li, Pansong Li, Wenzhang Fang, Haipeng Xu, Yuhua Gong, Zhengfei Zhu, Yi Hu, Wenhua Liang, Qian Chu, Wen-Zhao Zhong, Lin Wu, Huijuan Wang, Zhijie Wang, Ziming Li, Jie Lin, Yan-Fang Guan, Xuefeng Xia, Xin Yi, Qian Miao, Biao Wu, Kang Jiang, Xiaobin Zheng, Weifeng Zhu, Xinlong Zheng, Huang Peisha, Xiao Wenjin, Dan Hu, Longfeng Zhang, Xirong Fan, Tony Mok, Cheng Huang
- Abstract
Loading... -
+
MA21.03 - The International Association for the Study of Lung Cancer (IASLC) Global Survey on Molecular Testing in Lung Cancer
14:40 - 14:45 | Presenter: Matthew P Smeltzer | Author(s): Murry W Wynes, Meghan Taylor, Kristin Richeimer, Kelsey Wood, Kristen Howell, Mercedes Liliana Dalurzo, Enriqueta Felip, Keith Kerr, Edward Kim, Sylvie Lantuejoul, Clarissa Mathias, Pieter E. Postmus, Charles Powell, Suresh S Ramalingam, Ross Soo, Masahiro Tsuboi, Ignacio Wistuba, Marileila Varella-Garcia, Giorgio Vittorio Scagliotti, Fred R. Hirsch
- Abstract
Loading... -
+
MA21.04 - Discussant - MA21.01, MA21.02, MA21.03
14:45 - 15:00 | Presenter: Michael Duruisseaux
- Abstract
No abstract available for this presentation
-
+
MA21.05 - Phase II Trial of the Combination of Alectinib with Bevacizumab in ALK-Positive Nonsquamous Non-Small Cell Lung Cancer
15:00 - 15:05 | Presenter: Satoshi Watanabe | Author(s): Naoya Matsumoto, Jun Koshio, Akane Ishida, Tomohiro Tanaka, Tetsuya Abe, Daisuke Ishikawa, Satoshi Shoji, Koichiro Nozaki, Kosuke Ichikawa, Rie Kondo, Aya Otsubo, Ami Aoki, Tomosue Kajiwara, KENICHI Koyama, Satoru Miura, Hirohisa Yoshizawa, Toshiaki Kikuchi
- Abstract
Loading... -
+
MA21.06 - Preliminary Phase 1 Results of U3-1402 — A Novel HER3-Targeted Antibody–Drug Conjugate—in EGFR TKI-Resistant, EGFR-Mutant NSCLC
15:05 - 15:10 | Presenter: Helena A Yu | Author(s): Melissa Johnson, Conor E Steuer, Michele Vigliotti, Shuquan Chen, Yasuki Kamai, Channing Yu, Pasi A Jänne
- Abstract
Loading... -
+
MA21.07 - Circulating Tumor DNA Analysis Depicts Potential Mechanisms of Resistance to BRAF-Targeted Therapies in BRAF+ Non-Small Cell Lung Cancer
15:10 - 15:15 | Presenter: Sandra Ortiz-Cuaran | Author(s): Laura Mezquita, Aurélie Swalduz, Mihaela Aldea, Julien Mazieres, CECILE Jovelet, Washington René Chumbi Flores, LUDOVIC Lacroix, Yohan Loriot, Luc Friboulet, Virginie Westeel, Maud Ngocamus, Anne Pradines, Claire Tissot, Christelle Clement Duchene, Christine Raynaud, Xavier Quantin, Radj Gervais, Etienne Brain, Isabelle Monnet, Etienne Giroux Leprieur, Virginie Avrillon, Céline Mahier-Aït Oukhatar, Natalie Hoog-Labouret, Frank De Kievit, Karen Howarth, Jean-Francois Guichou, Clive Morris, Emma Green, Maurice Perol, Benjamin Besse, Jean-Yves Blay, Pierre Saintigny, David Planchard
- Abstract
Loading... -
+
MA21.08 - Discussant - MA21.05, MA21.06, MA21.07
15:15 - 15:30 | Presenter: Toyoaki Hida
- Abstract
No abstract available for this presentation
-
+
MA21.09 - Tyrosine Kinase Inhibitors' Plasma Concentration and Oncogene-Addicted Advanced Non-Small Lung Cancer (aNSCLC) Resistance
15:30 - 15:35 | Presenter: Arthur Geraud | Author(s): Laura Mezquita, Edouard Auclin, David Combarel, JULIA Delahousse, CHARLES Naltet, CECILE Jovelet, pernelle Lavaud, Anas Gazzah, LUDOVIC Lacroix, Jordi Remon, CAROLINE Caramella, David Planchard, OLIVIER Mir, ANGELO Paci, Benjamin Besse
- Abstract
Loading... -
+
MA21.10 - Phase II Study of 160mg of Osimertinib in EGFR T790M Positive NSCLC with Brain or Leptomeningeal Metastases Who Progressed on Prior EGFR TKI
15:35 - 15:40 | Presenter: Myung-Ju Ahn | Author(s): Sehhoon Park, Sunyoung Hong, JuYoun Park, MI RA Park, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park
- Abstract
Loading... -
+
MA21.11 - A Multicenter Phase II Study of Low-Dose Erlotinib in Frail Patients with EGFR Mutation-Positive, Non-Small Cell Lung Cancer: TORG1425
15:40 - 15:45 | Presenter: Sakiko Otani | Author(s): Kazuhiko Yamada, Shingo Miyamoto, Koichi Azuma, Hidenobu Ishii, Akihiro Bessho, Shinobu Hosokawa, Hideo Kunitoh, Kazuhito Miyazaki, Hiroshi Tanaka, Satoru Miura, Hiromi Aono, Yoshiro Nakahara, Kei Kusaka, Yukio Hosomi, Akinobu Hamada, Hiroaki Okamoto
- Abstract
Loading... -
+
MA21.12 - Discussant - MA21.09, MA21.10, MA21.11
15:45 - 16:00 | Presenter: Hong-Xu Liu
- Abstract
No abstract available for this presentation